Federal Awards · EMERGENT PRODUCT DEVELOPMENT GAITHERSBURG INC. · Award

IGF::OT::IGF, THE FIRST ORAL ANTIBIOTIC FOR THE TREATMENT OF ACUTE MELIODOSIS AND SELECT AGENTS" FOR MODIFI…

Award details are derived from public USAspending.gov records. Not a bid recommendation.

Award details

Award ID
HDTRA114C0122
Contractor
EMERGENT PRODUCT DEVELOPMENT GAITHERSBURG INC.
Awarding agency
Department of Defense
Sub-agency / office
Defense Threat Reduction Agency
Award amount
$16,072,041
Period of performance
Jun 8, 2018 – Aug 10, 2019
NAICS
541711 — Research and Development in Biotechnology
PSC
PSC AN12

Public award description

IGF::OT::IGF, THE FIRST ORAL ANTIBIOTIC FOR THE TREATMENT OF ACUTE MELIODOSIS AND SELECT AGENTS" FOR MODIFICATIONS P00011, 12 AND 13.

Source: USAspending.gov

Find out who's winning similar federal contracts

Discover comparable awards, related contractors, and agency purchasing history.

Don't take our word for it. Ask AI about RFPCapture.

See what leading AI assistants have to say about RFPCapture and CaptureIQ.

Gemini opens without a prefilled question. Click Gemini to copy the research question when your browser allows, or use Copy question.